Sign In

Login

Password

Forgot Password ? Sign Up

Infliksimab (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Infliksimab" in Serbian language version.

refsWebsite
Global rank Serbian rank
7nih.gov
4th place
8th place
7doi.org
2nd place
4th place
2archive.org
6th place
5th place

archive.org (Global: 6th place; Serbian: 5th place)

  • Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, et al.: Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Knight, David M.; Trinh, Han; Le, Junming; Siegel, Scott; Shealy, David; McDonough, Margaret; Scallon, Bernard; Moore, Maria Arevalo; Vilcek, Jan; Daddona, Peter; Ghrayeb, John (1993 Nov). „Construction and initial characterization of a mouse-human chimeric anti-TNF antibody”. Mol Immunol. 30 (16): 1443—53. PMID 8232330. doi:10.1016/0161-5890(93)90106-L.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, vanDeventer SJ: Infliximab maintenance therapy for fistulizing Crohn's disease. Sands, Bruce E.; Anderson, Frank H.; Bernstein, Charles N.; Chey, William Y.; Feagan, Brian G.; Fedorak, Richard N.; Kamm, Michael A.; Korzenik, Joshua R.; Lashner, Bret A.; Onken, Jane E.; Rachmilewitz, Daniel; Rutgeerts, Paul; Wild, Gary; Wolf, Douglas C.; Marsters, Paul A.; Travers, Suzanne B.; Blank, Marion A.; Van Deventer, Sander J. (2004 Feb 26). „Infliximab Maintenance Therapy for Fistulizing Crohn's Disease”. N Engl J Med. 350 (9): 876—85. PMID 14985485. doi:10.1056/NEJMoa030815.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)

doi.org (Global: 2nd place; Serbian: 4th place)

  • Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, et al.: Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Knight, David M.; Trinh, Han; Le, Junming; Siegel, Scott; Shealy, David; McDonough, Margaret; Scallon, Bernard; Moore, Maria Arevalo; Vilcek, Jan; Daddona, Peter; Ghrayeb, John (1993 Nov). „Construction and initial characterization of a mouse-human chimeric anti-TNF antibody”. Mol Immunol. 30 (16): 1443—53. PMID 8232330. doi:10.1016/0161-5890(93)90106-L.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Dubinsky MC, Fleshner PP: Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes. Dubinsky, Marla C.; Fleshner, Phillip P. (2003 Jun). „Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes”. Curr Treat Options Gastroenterol. 6 (3): 183—200. PMID 12744819. doi:10.1007/s11938-003-0001-1.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ: Infliximab for the treatment of fistulas in patients with Crohn's disease. Present, Daniel H.; Rutgeerts, Paul; Targan, Stephan; Hanauer, Stephen B.; Mayer, Lloyd; Van Hogezand, R.A.; Podolsky, Daniel K.; Sands, Bruce E.; Braakman, Tanja; Dewoody, Kimberly L.; Schaible, Thomas F.; Van Deventer, Sander J.H. (1999 May 6). „Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease”. N Engl J Med. 340 (18): 1398—405. PMID 10228190. doi:10.1056/NEJM199905063401804.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, vanDeventer SJ: Infliximab maintenance therapy for fistulizing Crohn's disease. Sands, Bruce E.; Anderson, Frank H.; Bernstein, Charles N.; Chey, William Y.; Feagan, Brian G.; Fedorak, Richard N.; Kamm, Michael A.; Korzenik, Joshua R.; Lashner, Bret A.; Onken, Jane E.; Rachmilewitz, Daniel; Rutgeerts, Paul; Wild, Gary; Wolf, Douglas C.; Marsters, Paul A.; Travers, Suzanne B.; Blank, Marion A.; Van Deventer, Sander J. (2004 Feb 26). „Infliximab Maintenance Therapy for Fistulizing Crohn's Disease”. N Engl J Med. 350 (9): 876—85. PMID 14985485. doi:10.1056/NEJMoa030815.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Hanauer SB: Crohn's disease: step up or top down therapy. Hanauer, Stephen B. (2003 Feb). „Crohn's disease: Step up or top down therapy”. Best Pract Res Clin Gastroenterol. 17 (1): 131—7. PMID 12617888. doi:10.1053/bega.2003.0361.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 

nih.gov (Global: 4th place; Serbian: 8th place)

ncbi.nlm.nih.gov

  • Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, et al.: Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Knight, David M.; Trinh, Han; Le, Junming; Siegel, Scott; Shealy, David; McDonough, Margaret; Scallon, Bernard; Moore, Maria Arevalo; Vilcek, Jan; Daddona, Peter; Ghrayeb, John (1993 Nov). „Construction and initial characterization of a mouse-human chimeric anti-TNF antibody”. Mol Immunol. 30 (16): 1443—53. PMID 8232330. doi:10.1016/0161-5890(93)90106-L.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Dubinsky MC, Fleshner PP: Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes. Dubinsky, Marla C.; Fleshner, Phillip P. (2003 Jun). „Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes”. Curr Treat Options Gastroenterol. 6 (3): 183—200. PMID 12744819. doi:10.1007/s11938-003-0001-1.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ: Infliximab for the treatment of fistulas in patients with Crohn's disease. Present, Daniel H.; Rutgeerts, Paul; Targan, Stephan; Hanauer, Stephen B.; Mayer, Lloyd; Van Hogezand, R.A.; Podolsky, Daniel K.; Sands, Bruce E.; Braakman, Tanja; Dewoody, Kimberly L.; Schaible, Thomas F.; Van Deventer, Sander J.H. (1999 May 6). „Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease”. N Engl J Med. 340 (18): 1398—405. PMID 10228190. doi:10.1056/NEJM199905063401804.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, vanDeventer SJ: Infliximab maintenance therapy for fistulizing Crohn's disease. Sands, Bruce E.; Anderson, Frank H.; Bernstein, Charles N.; Chey, William Y.; Feagan, Brian G.; Fedorak, Richard N.; Kamm, Michael A.; Korzenik, Joshua R.; Lashner, Bret A.; Onken, Jane E.; Rachmilewitz, Daniel; Rutgeerts, Paul; Wild, Gary; Wolf, Douglas C.; Marsters, Paul A.; Travers, Suzanne B.; Blank, Marion A.; Van Deventer, Sander J. (2004 Feb 26). „Infliximab Maintenance Therapy for Fistulizing Crohn's Disease”. N Engl J Med. 350 (9): 876—85. PMID 14985485. doi:10.1056/NEJMoa030815.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Hanauer SB: Crohn's disease: step up or top down therapy. Hanauer, Stephen B. (2003 Feb). „Crohn's disease: Step up or top down therapy”. Best Pract Res Clin Gastroenterol. 17 (1): 131—7. PMID 12617888. doi:10.1053/bega.2003.0361.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958.